Frederick Heinzel, MD, FACP

Associate Professor of Medicine, Division of Infectious Disease & International Medicine
Contact Information
Email: Frederick.heinzel@va.gov
Phone: (813) 972-2000 ext. 1748
FAX: (813) 978-5983
 Education
Fellowship, Infectious Disease, University of Washington, Seattle, WA
Internship and Residency, Internal Medicine, University of Washington Affiliated Hospitals, Seattle, WA
MD, University of California, Irvine
BS, Biochemistry, University of California, Davis

Biographical Sketch

Frederick Heinzel, MD, FACP is an Infectious Diseases Specialist and Immunologist with over fifty peer-reviewed publications related to basic and clinical studies of leishmaniasis, T-cell differentiation and the immunobiology of infection and trauma. He provides in-depth knowledge of the basic management, epidemiology and pathophysiology of parasitic and bacterial infections of global importance.

Dr. Heinzel was trained at the University of Washington in Infectious Diseases and was on the faculty at the University of California, San Francisco and Case Western Reserve University before joining the Division of Infectious Diseases and International Medicine at the University of South Florida.

Areas of Expertise

  • Human Leishmaniasis
  • Leprosy
  • Trypanosomiasis

Current Research

2008, DOD PT073012 Traumatic Brain Injury Concepts Grant "Pathogenesis of Heterotopic Ossification in Traumatic Brain Injury", 03/17/08-09/16/09

2003, VA Merit Review Award, "Immunotherapy of Chronic Infection", 4/01/03-3/31/06

2003, Frederick Heinzel (PI), NIH Training Grant T32-AI07024-26 “Training in Geographic Medicine and Infectious Diseases”, 9/1/03 - 8/31/08

Publications

Portillo JA, Muniz-Feliciano L, Heinzel F, Subauste C. CD40 and TNF-alpha Cooperate to Upregulate NOS2 Expression in Macrophages. Immunology, in press 2011

Yonkers, NL, Milkovich KA, Rodriguez B, Post AB, Asaad R, Heinzel FP, Tary-Lehmann M, Anthony DD. 2009. Accessory cell dependent NK cell mediated PBMC IFN-gamma production is defective in HIV infection. Clin. Immunol. 131:288-297

Daehnel, K, Gillette-Ferguson I, Hise AG, Diaconu E, Harling MJ, Heinzel FP, Pearlman E. 2007. Filaria/Wolbachia activation of dendritic cells and development of Th1-associated responses is dependent on Toll-like receptor 2 in a mouse model of ocular onchocerciasis (river blindness). Parasite Immunol. 29:455-65.

Gupta S, Gould MP, Devecchio J, Canaday DH, Auletta JJ, Heinzel FP. 2007. CpG-Induced IFN expands TLR4-specific IL-18 responses in vivo. Cell. Immunol. 243:75-82.

Greene JA, DeVecchio JL, Gould MP, Auletta JA, Heinzel FP. 2006. In vivo and in vitro regulation of type I IFN synthesis by synergistic effects of CD40 and Type II IFN. J. Immunol. 176:5995-6003.

Das L, DeVecchio JL, Heinzel FP. 2005. Flt3L-based immunoprophylaxis against infection is improved by adjuvant treatment with anti-IL-10 antibody. J of Infect Dis. 192:693-702.

Yadavalli GK, Chien JW, Wener KM, DeVecchio JL, Gupta S, Salata RA, Lee JH, Caldeira C, Auletta JJ, Heinzel FP. 2005. IL-12 and interferon-gamma synthetic deficiency is associated with dendritic cell cytopenia after cardiac surgery. Shock. 24:26-33.